← Eichor
Condition: Non Communicable Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Non Communicable Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AnovaOS Network Powered Patient Registry
Phase N/A · 1 location(s) · Anova Enterprises, Inc · NCT05013944Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care
Phase 4 · 13 location(s) · Uppsala University · NCT07236944Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants
Phase 1/Phase 2 · 1 location(s) · TenNor Therapeutics Inc. · NCT06889701Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest (OHCA)
NA · 1 location(s) · Hamad Medical Corporation · NCT05914779Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H
Phase 2 · 3 location(s) · Universiteit Antwerpen · NCT07407569Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
Phase 3 · 30 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05696093Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Zn Supplementation in HIV Immunological Non Responders
NA · 1 location(s) · Parc de Salut Mar · NCT06612554Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NA · 10 location(s) · Guangzhou 8th People's Hospital · NCT06947356Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
Phase N/A · 1 location(s) · The Geneva Foundation · NCT06402318Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Phase 2 · 1 location(s) · Loyola University · NCT05554068Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Alternative Prophylaxis in Female Recurrent Urinary Tract Infections
Phase 4 · 2 location(s) · University Hospital, Basel, Switzerland · NCT04095572Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia
NA · 1 location(s) · Mohamed Hosny Ismail Easa · NCT07123987Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
Phase 3 · 4 location(s) · Chang Gung Memorial Hospital · NCT06507059Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
Phase 2 · 6 location(s) · Novaliq GmbH · NCT07285070Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)
NA · 5 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05973201A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.
Phase 2 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07547995Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure
Phase N/A · 2 location(s) · Research Center Borstel · NCT07369414Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
Phase N/A · 18 location(s) · Hellenic Institute for the Study of Sepsis · NCT06601998Enabling Environments for Non-communicable Disease Risk Reduction in Ethiopia
NA · 4 location(s) · Norwegian Institute of Public Health · NCT07442318Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome
NA · 2 location(s) · Assiut University · NCT06996509Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Phase 4 · 1 location(s) · Mercy Medical Center · NCT04588077SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids
NA · 3 location(s) · Developeration AB · NCT05782010Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202052Health Warnings and Counseling for Smoking Cessation
NA · 1 location(s) · Hitotsubashi University · NCT07098065Early Life Intervention in Pediatrics Supported by E-health
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06208345
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.